XuanwuH Acute Ischemic Stroke Registry

Status Recruiting

Clinical Trial Summary

Acute ischemic stroke registry--Xuanwu Hospital(XSR) is an academic, independent, prospective, single center, observational registry study. Consecutive acute ischemic stroke patients assessed in stroke "green channel" of Xuanwu Hospital(China) will be enrolled in our study. Patients receive regular treatment and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of thrombolysis or thrombectomy, procedural complications, intracranial hemorrhage, and functional outcome.The study aim to investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients in "green channel",and verify the effect of the improvement of "green channel" process in the diagnosis and treatment of patients with acute ischemic stroke.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05208203
Study type	Observational [Patient Registry]
Source	Xuanwu Hospital, Beijing
Contact	qingfeng Ma, MD
Phone	+8613601069493
Email	m.qingfeng@163.com
Status	Recruiting
Phase
Start date	May 1, 2021
Completion date	December 31, 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04069546` - The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency	N/A
Recruiting	`NCT04415164` - Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke	Phase 4
Completed	`NCT05429658` - Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System	N/A
Recruiting	`NCT05390580` - Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct	N/A
Recruiting	`NCT05070260` - Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke	Phase 2/Phase 3
Completed	`NCT03366818` - New Stent Retriever, VERSI System for AIS	N/A
Recruiting	`NCT05547412` - Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke
Not yet recruiting	`NCT04984577` - Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke	Phase 2
Completed	`NCT02223273` - Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke)	N/A
Completed	`NCT02586233` - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke	Phase 1/Phase 2
Not yet recruiting	`NCT01594190` - Physical Activity Immediately After Acute Cerebral Ischemia	N/A
Terminated	`NCT01694381` - Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor	Early Phase 1
Completed	`NCT01120301` - Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)	Phase 3
Completed	`NCT01021319` - Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI)
Completed	`NCT00963989` - Imaging Guided Patient Selection for Interventional Revascularization Therapy	N/A
Recruiting	`NCT00710164` - Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke	Phase 2/Phase 3
Active, not recruiting	`NCT04072705` - Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
Recruiting	`NCT05492474` - Cranial Ultrasound for Prehospital ICH Diagnosis	N/A
Completed	`NCT04240470` - Endovascular Stroke Treatment Only (ESTO) Trial	N/A
Terminated	`NCT05101668` - Safety and Efficacy of Intracranial Thrombus Aspiration Catheter in the Treatment of Acute Large-vessel Occlusive Stroke	N/A